10 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 9.0% per year over the past 5 years.
Operating margin has expanded, at -9.0% in the latest year.
Free cash flow has declined 11.0% per year over the past 5 years.
Financial health
Operating income covered interest expense -72.3× in the latest year.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2026
$785M
-$65M
58.2%
-9.0%
$66M
—
$364M
2024
$584M
-$191M
53.4%
-28.3%
-$26M
—
$282M
2023
$782M
-$35M
58.9%
-3.1%
-$53M
—
$228M
2022
$1.0B
—
62.7%
11.6%
—
—
$500M
2022
$721M
—
59.0%
-4.6%
—
—
$1.1B
2021
$511M
—
57.7%
-21.0%
$118M
—
$203M
2019
$474M
—
59.1%
-18.7%
$151M
—
$227M
2018
$868M
—
60.1%
9.8%
$149M
—
$197M
2017
$769M
—
59.1%
11.1%
$177M
—
$269M
2016
$698M
—
60.4%
9.5%
$118M
$73M
$141M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Apr '26
$214M
-$16M
59.5%
-8.0%
-$5M
—
$383M
Jan '26
$208M
-$3M
63.4%
-1.6%
-$2M
—
$364M
Oct '25
$206M
-$10M
57.8%
-6.0%
$28M
—
$341M
Jul '25
$193M
-$22M
56.1%
-11.9%
-$4M
—
$314M
Apr '25
$178M
-$30M
55.0%
-18.1%
$43M
—
$325M
Dec '24
$166M
-$24M
54.3%
-17.2%
$6M
—
$282M
Sep '24
$166M
-$29M
54.3%
-17.9%
$29M
—
$303M
Jun '24
$145M
-$82M
52.7%
-33.0%
$13M
—
$241M
Mar '24
$106M
—
51.8%
-55.6%
-$74M
—
$191M
Dec '23
$87M
—
50.6%
-84.2%
—
—
$228M
Sep '23
$204M
—
58.4%
6.0%
-$38M
—
$160M
Jul '23
$245M
—
58.7%
7.0%
-$8M
—
$235M
Apr '23
$247M
—
62.3%
7.9%
-$21M
—
$716M
Dec '22
$257M
—
61.1%
9.4%
—
—
$500M
Oct '22
$270M
—
61.4%
11.2%
—
—
$483M
Jul '22
$263M
—
62.3%
11.9%
—
—
$505M
Apr '22
$234M
—
66.6%
14.4%
—
—
$766M
Jan '22
$209M
—
61.3%
1.3%
—
—
$1.1B
Oct '21
$185M
—
59.2%
-5.0%
—
—
$1.4B
Jul '21
$169M
—
56.8%
-6.8%
—
—
$303M
Valuation over time
How the market has priced SLAB against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 5.8× (Mar '23) to 9.2× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is SLAB growing its revenue and profit?
Over the past 5 years, Silicon Laboratories Inc.'s revenue has grown 9.0% per year. These are computed facts, not advice.
How much debt does SLAB have?
As of FY2026, Silicon Laboratories Inc. reported — of total debt against $364M of cash; operating income covered interest expense -72.3×.
What is SLAB's profit margin?
In FY2026, gross margin was 58.2%, operating margin -9.0%, and net margin -8.3%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.